In a retrospective study on 15 patients with BRC-resistant, invasive, giant prolactinomas, Huang et al. showed that CAB was effective in normalising serum PRL levels, reducing tumour size, and improving neurological symptoms [14]. This evidence concerns the gene PRL and prolactin-producing pituitary gland adenoma.